Walking capacities in multiple sclerosis measured by global positioning system odometer

被引:31
作者
Creange, A. [1 ]
Serre, I.
Levasseur, M.
Audry, D.
Nineb, A.
Boerio, D.
Moreau, T.
Maison, P.
机构
[1] Hop Henri Mondor, AP HP, Serv Neurol, F-94010 Creteil, France
[2] Univ Paris 12, F-94010 Creteil, France
[3] Ctr Hosp Sud Francilien, Serv Neurol, Corbeil Essonnes, France
[4] Ctr Hosp, Serv Neurol, Orsay, France
[5] Ctr Hosp Univ, Serv Neurol, Dijon, France
来源
MULTIPLE SCLEROSIS | 2007年 / 13卷 / 02期
关键词
ambulation; multiple sclerosis; odometer; walking capacities;
D O I
10.1177/1352458506070667
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We used a global positioning satellite technology odometer to determine the maximum objective walking distance capacity (MOWD) of patients with multiple sclerosis (MS). The MOWD correlated with Expanded Disability Status Scale (EDSS) score (r(2)=0.41; P<0.0001), the MSWS-12 scale (r(2)=0.46; P<0.0001), time to walk 10 m (r(2)=0.51; P<0.02) and walking speed (r(2)=0.75; P<0.001). Limitation of walking capacities was measurable up to 4550 m, strikingly above the 500-m limit of the EDSS. This objective odometer is a promising tool for evaluation and follow-up of patients with MS.
引用
收藏
页码:220 / 223
页数:4
相关论文
共 11 条
[1]
Accuracy of five electronic pedometers for measuring distance walked [J].
Bassett, DR ;
Ainsworth, BE ;
Leggett, SR ;
Mathien, CA ;
Main, JA ;
Hunter, DC ;
Duncan, GE .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1996, 28 (08) :1071-1077
[2]
FISCHER JS, 1999, ADM SCORIGN MANUAL M
[3]
INTENSIVE IMMUNOSUPPRESSION IN PROGRESSIVE MULTIPLE-SCLEROSIS - A RANDOMIZED, 3-ARM STUDY OF HIGH-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE, PLASMA-EXCHANGE, AND ACTH [J].
HAUSER, SL ;
DAWSON, DM ;
LEHRICH, JR ;
BEAL, MF ;
KEVY, SV ;
PROPPER, RD ;
MILLS, JA ;
WEINER, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (04) :173-180
[4]
Measuring the impact of MS on walking ability - The 12-Item MS Walking Scale (MSWS-12) [J].
Hobart, JC ;
Riazi, A ;
Lamping, DL ;
Fitzpatrick, R ;
Thompson, AJ .
NEUROLOGY, 2003, 60 (01) :31-36
[5]
Comparisons of patient self-report, neurologic examination, and functional impairment in MS [J].
Hoogervorst, ELJ ;
van Winsen, LML ;
Eikelenboom, MJ ;
Kalkers, NF ;
Uitdehaag, BMJ ;
Polman, CH .
NEUROLOGY, 2001, 56 (07) :934-937
[6]
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[7]
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis [J].
McDonald, WI ;
Compston, A ;
Edan, G ;
Goodkin, D ;
Hartung, HP ;
Lublin, FD ;
McFarland, HF ;
Paty, DW ;
Polman, CH ;
Reingold, SC ;
Sandberg-Wollheim, M ;
Sibley, W ;
Thompson, AJ ;
van den Noort, S ;
Weinshenker, BY ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 50 (01) :121-127
[8]
Commercially available pedometers: considerations for accurate step counting [J].
Melanson, EL ;
Knoll, JR ;
Bell, ML ;
Donahoo, WT ;
Hill, JO ;
Nysse, LJ ;
Lanningham-Foster, L ;
Peters, JC ;
Levine, JA .
PREVENTIVE MEDICINE, 2004, 39 (02) :361-368
[9]
Speed and exercise intensity of recreational walkers [J].
Murtagh, EM ;
Boreham, CAG ;
Murphy, MH .
PREVENTIVE MEDICINE, 2002, 35 (04) :397-400
[10]
The role of pedometers in the assessment of intermittent claudication [J].
Nasr, MK ;
McCarthy, RJ ;
Walker, RA ;
Horrocks, M .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2002, 23 (04) :317-320